Guizhou Sanli Pharmaceutical Co Ltd (603439)

Currency in CNY
13.20
+0.03(+0.23%)
Closed·
603439 Scorecard
Full Analysis
Management has been aggressively buying back shares
603439 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.0813.25
52 wk Range
10.6916.50
Key Statistics
Bid/Ask
13.19 / 13.20
Prev. Close
13.17
Open
13.15
Day's Range
13.08-13.25
52 wk Range
10.69-16.5
Volume
7.5M
Average Volume (3m)
9.57M
1-Year Change
11.58%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603439 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Guizhou Sanli Pharmaceutical Co Ltd Company Profile

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Anshun, China.

Employees
2852
Market
China

Compare 603439 to Peers and Sector

Metrics to compare
603439
Peers
Sector
Relationship
P/E Ratio
20.4x30.5x−0.5x
PEG Ratio
−1.56−0.170.00
Price/Book
3.4x3.2x2.6x
Price / LTM Sales
2.5x4.7x3.3x
Upside (Analyst Target)
-10.6%43.4%
Fair Value Upside
Unlock18.0%7.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.63%
Dividend Yield
2.58%
Industry Median 1.51%
Annualised payout
0.34
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.10 / --
Revenue / Forecast
408.59M / --
EPS Revisions
Last 90 days

603439 Income Statement

FAQ

What Stock Exchange Does Guizhou Sanli Pharmaceutical Co Trade On?

Guizhou Sanli Pharmaceutical Co is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Guizhou Sanli Pharmaceutical Co?

The stock symbol for Guizhou Sanli Pharmaceutical Co is "603439."

What Is the Guizhou Sanli Pharmaceutical Co Market Cap?

As of today, Guizhou Sanli Pharmaceutical Co market cap is 5.31B.

What Is Guizhou Sanli Pharmaceutical Co's Earnings Per Share (TTM)?

The Guizhou Sanli Pharmaceutical Co EPS (TTM) is 0.63.

When Is the Next Guizhou Sanli Pharmaceutical Co Earnings Date?

Guizhou Sanli Pharmaceutical Co will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 603439 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Guizhou Sanli Pharmaceutical Co Stock Split?

Guizhou Sanli Pharmaceutical Co has split 0 times.

How Many Employees Does Guizhou Sanli Pharmaceutical Co Have?

Guizhou Sanli Pharmaceutical Co has 2852 employees.

What is the current trading status of Guizhou Sanli Pharmaceutical Co (603439)?

As of 10 Aug 2025, Guizhou Sanli Pharmaceutical Co (603439) is trading at a price of 13.20, with a previous close of 13.17. The stock has fluctuated within a day range of 13.08 to 13.25, while its 52-week range spans from 10.69 to 16.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.